Compare NB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NB | LENZ |
|---|---|---|
| Founded | 1987 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.8M | 852.0M |
| IPO Year | N/A | 2021 |
| Metric | NB | LENZ |
|---|---|---|
| Price | $5.88 | $30.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $5.75 | ★ $56.25 |
| AVG Volume (30 Days) | ★ 5.5M | 1.3M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $285.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $16.54 |
| 52 Week High | $12.58 | $50.40 |
| Indicator | NB | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 50.48 |
| Support Level | $5.03 | $27.44 |
| Resistance Level | $6.31 | $32.13 |
| Average True Range (ATR) | 0.53 | 2.14 |
| MACD | 0.07 | 0.98 |
| Stochastic Oscillator | 56.85 | 76.99 |
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.